<h4>Background</h4>Atypical chronic myeloid leukemia (aCML) is a <i>BCR::ABL1</i> negative myelodysplastic/myeloproliferative neoplasm with poor overall survival. This evidence concerns the gene BCR and myeloproliferative neoplasm.